ABI
AGN

Adamant Biomedical Investments’s Allergan Inc AGN Stock Holding History

Adamant Biomedical Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$7.44M Hold
35,000
– – 1.78% 17
2014
Q3 		$6.24M Buy
+35,000
New +$5.81M 1.56% 21

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adamant Biomedical Investments's AGN Position: Q4 2014 in Review

Adamant Biomedical Investments held its Allergan Inc (AGN) position steady in Q4 2014 at 35,000 shares worth $7.44M. The position accounts for 1.78% of the portfolio, ranked #17.

Adamant Biomedical Investments first reported a position in AGN in Q3 2014 and has held it in 2 quarters since. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Adamant Biomedical Investments held 35,000 shares of Allergan Inc worth $7.44M as of Q4 2014.
  • Adamant Biomedical Investments left its Allergan Inc share count unchanged in Q4 2014.
  • Allergan Inc made up 1.78% of Adamant Biomedical Investments's portfolio in Q4 2014, its #17 holding.
  • Adamant Biomedical Investments first reported a position in Allergan Inc in Q3 2014 and has held it in 2 quarters since.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.